AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
NOVEL MOLECULAR TARGETS FOR THE TREATMENT OF OBESITY (VOL 3, PG 250, 1998)
Authors: STRADER CD
Citation: Cd. Strader, NOVEL MOLECULAR TARGETS FOR THE TREATMENT OF OBESITY (VOL 3, PG 250, 1998), Drug discovery today, 3(9), 1998, pp. 431-431
NOVEL MOLECULAR TARGETS FOR THE TREATMENT OF OBESITY
Authors: STRADER CD HWA JJ VANHEEK M PARKER EM
Citation: Cd. Strader et al., NOVEL MOLECULAR TARGETS FOR THE TREATMENT OF OBESITY, Drug discovery today, 3(6), 1998, pp. 250-256
EFFECT OF CHRONIC CENTRAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE ON FOOD-CONSUMPTION AND BODY-WEIGHT IN NORMAL AND OBESE RATS
Authors: DAVIS HR MULLINS DE PINES JM HOOS LM FRANCE CF COMPTON DS GRAZIANO MP SYBERTZ EF STRADER CD VANHEEK M
Citation: Hr. Davis et al., EFFECT OF CHRONIC CENTRAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE ON FOOD-CONSUMPTION AND BODY-WEIGHT IN NORMAL AND OBESE RATS, Obesity research, 6(2), 1998, pp. 147-156
POTENT, SELECTIVE BENZENESULFONAMIDE AGONISTS OF THE HUMAN BETA(3) ADRENERGIC-RECEPTOR
Authors: WEBER AE MATHVINK RJ PERKINS L HUTCHINS JE CANDELORE MR TOTA L STRADER CD WYVRATT MJ FISHER MH
Citation: Ae. Weber et al., POTENT, SELECTIVE BENZENESULFONAMIDE AGONISTS OF THE HUMAN BETA(3) ADRENERGIC-RECEPTOR, Bioorganic & medicinal chemistry letters, 8(9), 1998, pp. 1101-1106
DISCOVERY OF L-755,507 - A SUBNANOMOLAR HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST
Authors: PARMEE ER OK HO CANDELORE MR TOTA L DENG LP STRADER CD WYVRATT MJ FISHER MH WEBER AE
Citation: Er. Parmee et al., DISCOVERY OF L-755,507 - A SUBNANOMOLAR HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST, Bioorganic & medicinal chemistry letters, 8(9), 1998, pp. 1107-1112
3-PYRIDYLETHANOLAMINES - POTENT AND SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONISTS
Authors: NAYLOR EM COLANDREA VJ CANDELORE MR CASCIERI MA COLWELL LF DENG LP FEENEY WP FORREST MJ HOM GJ MACINTYRE DE STRADER CD TOTA L WANG PR WYVRATT MJ FISHER MH WEBER AE
Citation: Em. Naylor et al., 3-PYRIDYLETHANOLAMINES - POTENT AND SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONISTS, Bioorganic & medicinal chemistry letters, 8(21), 1998, pp. 3087-3092
3-PYRIDYLOXYPROPANOLAMINE AGONISTS OF THE BETA(3) ADRENERGIC-RECEPTORWITH IMPROVED PHARMACOKINETIC PROPERTIES
Authors: WEBER AE OK HO ALVARO RF CANDELORE MR CASCIERI MA CHIU SHL DENG LP FORREST MJ HOM GJ HUTCHINS JE KAO J MACINTYRE DE MATHVINK RJ MCLOUGHLIN D MILLER RR NEWBOLD RC OLAH TV PARMEE ER PERKINS L STEARNS RA STRADER CD SZUMILOSKI J TANG YS TOTA L VICARIO PP WYVRATT MJ FISHER MH
Citation: Ae. Weber et al., 3-PYRIDYLOXYPROPANOLAMINE AGONISTS OF THE BETA(3) ADRENERGIC-RECEPTORWITH IMPROVED PHARMACOKINETIC PROPERTIES, Bioorganic & medicinal chemistry letters, 8(16), 1998, pp. 2111-2116
DIFFERENTIAL-EFFECTS OF INTRACEREBROVENTRICULAR GLUCAGON-LIKE PEPTIDE-1 ON FEEDING AND ENERGY-EXPENDITURE REGULATION
Authors: HWA JJ GHIBAUDI L WILLIAMS P WITTEN MB TEDESCO R STRADER CD
Citation: Jj. Hwa et al., DIFFERENTIAL-EFFECTS OF INTRACEREBROVENTRICULAR GLUCAGON-LIKE PEPTIDE-1 ON FEEDING AND ENERGY-EXPENDITURE REGULATION, Peptides (New York, N.Y. 1980), 19(5), 1998, pp. 869-875
A SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST INCREASES METABOLIC-RATE IN RHESUS-MONKEYS
Authors: FISHER MH AMEND AM BACH TJ BARKER JM BRADY EJ CANDELORE MR CARROLL D CASCIERI MA CHIU SHL DENG LP FORREST MJ HEGARTYFRISCINO B GUAN XM HOM GJ HUTCHINS JE KELLY LJ MATHVINK RJ METZGER JM MILLER RR OK HO PARMEE ER SAPERSTEIN R STRADER CD STEARNS RA THOMPSON GM TOTA L VICARIO PP WEBER AE WOODS JW WYVRATT MJ ZAFIAN PT MACINTYRE DE
Citation: Mh. Fisher et al., A SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST INCREASES METABOLIC-RATE IN RHESUS-MONKEYS, The Journal of clinical investigation, 101(11), 1998, pp. 2387-2393
MOLECULAR APPROACHES TO THE DISCOVERY OF NEW TREATMENTS FOR OBESITY
Authors: STRADER CD MACINTYRE DE CANDELORE MR PARKER EM
Citation: Cd. Strader et al., MOLECULAR APPROACHES TO THE DISCOVERY OF NEW TREATMENTS FOR OBESITY, CURRENT OPINION IN CHEMICAL BIOLOGY, 1(2), 1997, pp. 204-209
LEPTIN INCREASES ENERGY-EXPENDITURE AND SELECTIVELY PROMOTES FAT-METABOLISM IN OB OB MICE/
Authors: HWA JJ FAWZI AB GRAZIANO MP GHIBAUDI L WILLIAMS P VANHEEK M DAVIS H RUDINSKI M SYBERTZ E STRADER CD
Citation: Jj. Hwa et al., LEPTIN INCREASES ENERGY-EXPENDITURE AND SELECTIVELY PROMOTES FAT-METABOLISM IN OB OB MICE/, American journal of physiology. Regulatory, integrative and comparative physiology, 41(4), 1997, pp. 1204-1209
EXPRESSION OF B-1 AND B-2 BRADYKININ RECEPTOR MESSENGER-RNA AND THEIRFUNCTIONAL ROLES IN SYMPATHETIC-GANGLIA AND SENSORY DORSAL-ROOT GANGLIA NEURONS FROM WILD-TYPE AND B-2 RECEPTOR KNOCKOUT MICE
Authors: SEABROOK GR BOWERY BJ HEAVENS R BROWN N FORD H SIRINATHSINGHI DJS BORKOWSKI JA HESS JF STRADER CD HILL RG
Citation: Gr. Seabrook et al., EXPRESSION OF B-1 AND B-2 BRADYKININ RECEPTOR MESSENGER-RNA AND THEIRFUNCTIONAL ROLES IN SYMPATHETIC-GANGLIA AND SENSORY DORSAL-ROOT GANGLIA NEURONS FROM WILD-TYPE AND B-2 RECEPTOR KNOCKOUT MICE, Neuropharmacology, 36(7), 1997, pp. 1009-1017
DIET-INDUCED OBESE MICE DEVELOP PERIPHERAL, BUT NOT CENTRAL, RESISTANCE TO LEPTIN
Authors: VANHEEK M COMPTON DS FRANCE CF TEDESCO RP FAWZI AB GRAZIANO MP SYBERTZ EJ STRADER CD DAVIS HR
Citation: M. Vanheek et al., DIET-INDUCED OBESE MICE DEVELOP PERIPHERAL, BUT NOT CENTRAL, RESISTANCE TO LEPTIN, The Journal of clinical investigation, 99(3), 1997, pp. 385-390
GENOMIC ORGANIZATION AND FUNCTIONAL-CHARACTERIZATION OF THE MOUSE GALR1 GALANIN RECEPTOR
Authors: WANG SK HE CG MAGUIRE MT CLEMMONS AL BURRIER RE GUZZI MF STRADER CD PARKER EM BAYNE ML
Citation: Sk. Wang et al., GENOMIC ORGANIZATION AND FUNCTIONAL-CHARACTERIZATION OF THE MOUSE GALR1 GALANIN RECEPTOR, FEBS letters, 411(2-3), 1997, pp. 225-230
CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST
Authors: CASCIERI MA BER E FONG TM HALE JJ TANG F SHIAO LL MILLS SG MACCOSS M SADOWSKI S TOTA MR STRADER CD
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST, European journal of pharmacology, 325(2-3), 1997, pp. 253-261
PRESENILIN MUTATIONS IN ALZHEIMERS-DISEASE - MOLECULAR-MODELS SUGGESTA POTENTIAL FUNCTIONAL LOCUS (VOL 17, PG 389, 1996)
Authors: MURGOLO NJ BROWN JE BAYNE ML STRADER CD
Citation: Nj. Murgolo et al., PRESENILIN MUTATIONS IN ALZHEIMERS-DISEASE - MOLECULAR-MODELS SUGGESTA POTENTIAL FUNCTIONAL LOCUS (VOL 17, PG 389, 1996), Trends in pharmacological sciences, 17(12), 1996, pp. 465-465
PRESENILIN MUTATIONS IN ALZHEIMERS-DISEASE - MOLECULAR-MODELS SUGGESTA POTENTIAL FUNCTIONAL LOCUS
Authors: MURGOLO NJ BROWN JE BAYNE ML STRADER CD
Citation: Nj. Murgolo et al., PRESENILIN MUTATIONS IN ALZHEIMERS-DISEASE - MOLECULAR-MODELS SUGGESTA POTENTIAL FUNCTIONAL LOCUS, Trends in pharmacological sciences, 17(11), 1996, pp. 389-393
PURIFICATION AND RECONSTITUTION OF A RECOMBINANT HUMAN NEUROKININ-1 RECEPTOR
Authors: MAZINA KE STRADER CD TOTA MR DANIEL S FONG TM
Citation: Ke. Mazina et al., PURIFICATION AND RECONSTITUTION OF A RECOMBINANT HUMAN NEUROKININ-1 RECEPTOR, Journal of receptor and signal transduction research, 16(3-4), 1996, pp. 191-207
THE AMINO-TERMINAL DOMAIN OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR IS A CRITICAL DETERMINANT OF SUBTYPE SPECIFICITY
Authors: GRAZIANO MP HEY PJ STRADER CD
Citation: Mp. Graziano et al., THE AMINO-TERMINAL DOMAIN OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR IS A CRITICAL DETERMINANT OF SUBTYPE SPECIFICITY, Receptors & channels, 4(1), 1996, pp. 9-17
NOCICEPTION AND INFLAMMATORY HYPERALGESIA IN B-2 BRADYKININ RECEPTOR KNOCKOUT MICE
Authors: BOYCE S RUPNIAK NMJ CARLSON EJ WEBB J BORKOWSKI JA HESS JF STRADER CD HILL RG
Citation: S. Boyce et al., NOCICEPTION AND INFLAMMATORY HYPERALGESIA IN B-2 BRADYKININ RECEPTOR KNOCKOUT MICE, Immunopharmacology, 33(1-3), 1996, pp. 333-335
NYL-4-((3-OXO-1,2,4-TRIAZOL-5-YL)METHYL)MORPHOLINE .1. A POTENT, ORALLY-ACTIVE, MORPHOLINE-BASED HUMAN NEUROKININ-1 RECEPTOR ANTAGONIST
Authors: HALE JJ MILLS SG MACCOSS M SHAH SK QI HB MATHRE DJ CASCIERI MA SADOWSKI S STRADER CD MACINTYRE DE METZGER JM
Citation: Jj. Hale et al., NYL-4-((3-OXO-1,2,4-TRIAZOL-5-YL)METHYL)MORPHOLINE .1. A POTENT, ORALLY-ACTIVE, MORPHOLINE-BASED HUMAN NEUROKININ-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 39(9), 1996, pp. 1760-1762
SYNTHESIS OF POTENT CYCLIC HEXAPEPTIDE NK-1 ANTAGONISTS - USE OF A MINILIBRARY IN TRANSFORMING A PEPTIDAL SOMATOSTATIN RECEPTOR-LIGAND INTOAN NK-1 RECEPTOR-LIGAND VIA A POLYVALENT PEPTIDOMIMETIC
Authors: HIRSCHMANN R YAO WQ CASCIERI MA STRADER CD MAECHLER L CICHYKNIGHT MA HYNES J VANRIJN RD SPRENGELER PA SMITH AB
Citation: R. Hirschmann et al., SYNTHESIS OF POTENT CYCLIC HEXAPEPTIDE NK-1 ANTAGONISTS - USE OF A MINILIBRARY IN TRANSFORMING A PEPTIDAL SOMATOSTATIN RECEPTOR-LIGAND INTOAN NK-1 RECEPTOR-LIGAND VIA A POLYVALENT PEPTIDOMIMETIC, Journal of medicinal chemistry, 39(13), 1996, pp. 2441-2448
THE VIEW FROM INSIDE THE RECEPTOR
Authors: STRADER CD
Citation: Cd. Strader, THE VIEW FROM INSIDE THE RECEPTOR, Journal of medicinal chemistry, 39(1), 1996, pp. 1-1
CLONING AND EXPRESSION OF A NOVEL NEUROPEPTIDE-Y RECEPTOR
Authors: WEINBERG DH SIRINATHSINGHJI DJS TAN CP SHIAO LL MORIN N RIGBY MR HEAVENS RH RAPOPORT DR BAYNE ML CASCIERI MA STRADER CD LINEMEYER DL MACNEIL DJ
Citation: Dh. Weinberg et al., CLONING AND EXPRESSION OF A NOVEL NEUROPEPTIDE-Y RECEPTOR, The Journal of biological chemistry, 271(28), 1996, pp. 16435-16438
DOWN-REGULATION OF THE EXPRESSION OF THE OBESE GENE BY AN ANTIDIABETIC THIAZOLIDINEDIONE IN ZUCKER DIABETIC FATTY RATS AND DB DB MICE/
Authors: ZHANG B GRAZIANO MP DOEBBER TW LEIBOWITZ MD WHITECARRINGTON S SZALKOWSKI DM HEY PJ WU M CULLINAN CA BAILEY P LOLLMANN B FREDERICH R FLIER JS STRADER CD SMITH RG
Citation: B. Zhang et al., DOWN-REGULATION OF THE EXPRESSION OF THE OBESE GENE BY AN ANTIDIABETIC THIAZOLIDINEDIONE IN ZUCKER DIABETIC FATTY RATS AND DB DB MICE/, The Journal of biological chemistry, 271(16), 1996, pp. 9455-9459
Risultati: 1-25 | 26-50 | 51-69